Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial infarction assessed at baseline and 2 h

被引:7
作者
Cullen, Louise [1 ,2 ,3 ]
Greenslade, Jaimi [1 ,2 ,3 ]
Parsonage, William [2 ,4 ]
Stephensen, Laura [1 ]
Smith, Stephen W. [5 ]
Sandoval, Yader [6 ,7 ]
Ranasinghe, Isuru [3 ,8 ]
Gaikwad, Niranjan [8 ]
Bayat, Maryam Khorramshahi [8 ]
Mahmoodi, Ehsan [8 ]
Schulz, Karen [9 ]
Than, Martin [10 ]
Apple, Fred S. [9 ,11 ]
机构
[1] Royal Brisbane & Womens Hosp, Emergency & Trauma Ctr, Butterfield St, Herston, Qld 4029, Australia
[2] Queensland Univ Technol, Fac Hlth, Australian Ctr Hlth Serv Innovat, Ctr Healthcare Transformat,Sch Publ Hlth & Social, Musk Ave, Kelvin Grove, Qld 4059, Australia
[3] Univ Queensland, Fac Med, Herston Rd, Herston, Qld 4006, Australia
[4] Royal Brisbane & Womens Hosp, Dept Cardiol, Brisbane, Australia
[5] Univ Minnesota, Hennepin Healthcare Hennepin Cty Med Ctr, Dept Emergency Med, Sch Med, Minneapolis, MN USA
[6] Abbott NW Hosp, Minneapolis Heart Inst, Minneapolis, MN USA
[7] Minneapolis Heart Inst Fdn, Ctr Coronary Artery Dis, Minneapolis, MN USA
[8] Prince Charles Hosp, Dept Cardiol, Brisbane, Qld, Australia
[9] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN USA
[10] Christchurch Hosp, Emergency Dept, Christchurch, New Zealand
[11] Hennepin Healthcare Hennepin Cty Med Ctr, Clin & Forens Toxicol Lab, Minneapolis, MN USA
关键词
Emergency department; Myocardial infarction; High-sensitivity troponin; Rapid diagnostics; Point of care; DIAGNOSIS; GUIDELINES;
D O I
10.1093/eurheartj/ehae343
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Aims Strategies to assess patients with suspected acute myocardial infarction (AMI) using a point-of-care (POC) high-sensitivity cardiac troponin I (hs-cTnI) assay may expedite emergency care. A 2-h POC hs-cTnI strategy for emergency patients with suspected AMI was derived and validated.Methods In two international, multi-centre, prospective, observational studies of adult emergency patients (1486 derivation cohort and 1796 validation cohort) with suspected AMI, hs-cTnI (Siemens Atellica (R) VTLi) was measured at admission and 2 h later. Adjudicated final diagnoses utilized the hs-cTn assay in clinical use. A risk stratification algorithm was derived and validated. The primary diagnostic outcome was index AMI (Types 1 and 2). The primary safety outcome was 30-day major adverse cardiac events incorporating AMI and cardiac death.Results Overall, 81 (5.5%) and 88 (4.9%) patients in the derivation and validation cohorts, respectively, had AMI. The 2-h algorithm defined 66.1% as low risk with a sensitivity of 98.8% [95% confidence interval (CI) 89.3%-99.9%] and a negative predictive value of 99.9 (95% CI 99.2%-100%) for index AMI in the derivation cohort. In the validation cohort, 53.3% were low risk with a sensitivity of 98.9% (95% CI 92.4%-99.8%) and a negative predictive value of 99.9% (95% CI 99.3%-100%) for index AMI. The high-risk metrics identified 5.4% of patients with a specificity of 98.5% (95% CI 96.6%-99.4%) and a positive predictive value of 74.5% (95% CI 62.7%-83.6%) for index AMI.Conclusions A 2-h algorithm using a POC hs-cTnI concentration enables safe and efficient risk assessment of patients with suspected AMI. The short turnaround time of POC testing may support significant efficiencies in the management of the large proportion of emergency patients with suspected AMI. Structured Graphical Abstract Performance of the 0-/2-h algorithm for risk assessment of myocardial infarction in the Suspected Acute Myocardial Infarction in Emergency (SAMIE) and Safe Emergency Department Discharge Rate (SEIGE) cohorts. AMI, acute myocardial infarction; CI, confidence interval; hs-cTnI, high-sensitivity cardiac troponin I; NPV, negative predictive value; POC, point of care; PPV, positive predictive value.
引用
收藏
页码:2508 / 2515
页数:8
相关论文
共 25 条
  • [1] [Anonymous], 2015, National Hospital Ambulatory Medical Care Survey
  • [2] Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay
    Apple, Fred S.
    Schulz, Karen
    Schmidt, Christian W.
    van Domburg, Trees S. Y.
    Fonville, Judith M.
    de Theije, Femke K.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (09) : 1574 - 1578
  • [3] Single High-Sensitivity Point-of-Care Whole-Blood Cardiac Troponin I Measurement to Rule Out Acute Myocardial Infarction at Low Risk
    Apple, Fred S.
    Smith, Stephen W.
    Greenslade, Jaimi H.
    Sandoval, Yader
    Parsonage, William
    Ranasinghe, Isuru
    Gaikwad, Niranjan
    Schulz, Karen
    Stephensen, Laura
    Schmidt, Christian W.
    Okeson, Brynn
    Cullen, Louise
    [J]. CIRCULATION, 2022, 146 (25) : 1918 - 1929
  • [4] Cardiac Troponin Assays: Guide to Understanding Analytical Characteristics and Their Impact on Clinical Care
    Apple, Fred S.
    Sandoval, Yader
    Jaffe, Allan S.
    Ordonez-Llanos, Jordi
    [J]. CLINICAL CHEMISTRY, 2017, 63 (01) : 73 - 81
  • [5] Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
    Apple, Fred S.
    Collinson, Paul O.
    [J]. CLINICAL CHEMISTRY, 2012, 58 (01) : 54 - 61
  • [6] Early Diagnosis of Myocardial Infarction With Point-of-Care High-Sensitivity Cardiac Troponin I
    Boeddinghaus, Jasper
    Nestelberger, Thomas
    Koechlin, Luca
    Wussler, Desiree
    Lopez-Ayala, Pedro
    Walter, Joan Elias
    Troester, Valentina
    Ratmann, Paul David
    Seidel, Funda
    Zimmermann, Tobias
    Badertscher, Patrick
    Wildi, Karin
    Gimenez, Maria Rubini
    Potlukova, Eliska
    Strebel, Ivo
    Freese, Michael
    Miro, Oscar
    Javier Martin-Sanchez, F.
    Kawecki, Damian
    Keller, Dagmar I.
    Gualandro, Danielle M.
    Christ, Michael
    Twerenbold, Raphael
    Mueller, Christian
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (10) : 1111 - 1124
  • [7] Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction
    Boeddinghaus, Jasper
    Twerenbold, Raphael
    Nestelberger, Thomas
    Badertscher, Patrick
    Wildi, Karin
    Puelacher, Christian
    de Lavallaz, Jeanne du Fay
    Keser, Elif
    Gimenez, Maria Rubini
    Wussler, Desiree
    Kozhuharov, Nikola
    Rentsch, Katharina
    Miro, Oscar
    Martin-Sanchez, F. Javier
    Morawiec, Beata
    Stefanelli, Sabrina
    Geigy, Nicolas
    Keller, Dagmar I.
    Reichlin, Tobias
    Mueller, Christian
    [J]. CLINICAL CHEMISTRY, 2018, 64 (09) : 1347 - 1360
  • [8] 2023 ESC Guidelines for the management of acute coronary syndromes
    Byrne, Robert A.
    Rossello, Xavier
    Coughlan, J. J.
    Barbato, Emanuele
    Berry, Colin
    Chieffo, Alaide
    Claeys, Marc J.
    Dan, Gheorghe-Andrei
    Dweck, Marc R.
    Galbraith, Mary
    Gilard, Martine
    Hinterbuchner, Lynne
    Jankowska, Ewa A.
    Juni, Peter
    Kimura, Takeshi
    Kunadian, Vijay
    Leosdottir, Margret
    Lorusso, Roberto
    Pedretti, Roberto F. E.
    Rigopoulos, Angelos G.
    Gimenez, Maria Rubini
    Thiele, Holger
    Vranckx, Pascal
    Wassmann, Sven
    Wenger, Nanette Kass
    Ibanez, Borja
    ESC Sci Document Grp
    [J]. EUROPEAN HEART JOURNAL, 2023, 44 (38) : 3720 - 3826
  • [9] National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Management of Acute Coronary Syndromes 2016
    Chew, Derek P.
    Scott, Ian A.
    Cullen, Louise
    French, John K.
    Briffa, Tom G.
    Tideman, Philip A.
    Woodruffe, Stephen
    Kerr, Alistair
    Branagan, Maree
    Aylward, Philip E. G.
    [J]. HEART LUNG AND CIRCULATION, 2016, 25 (09) : 895 - 951
  • [10] Point-of-Care: Roadmap for Analytical Characterization and Validation of a High-Sensitivity Cardiac Troponin I Assay in Plasma and Whole Blood Matrices
    Christenson, Robert H.
    Frenk, Lisa D. S.
    de Graaf, Henk J.
    van Domburg, Trees S. Y.
    Wijnands, Frank P. G.
    Foolen, Helma W. J.
    Kemper, Danielle W. M.
    Bruinen, Anne L.
    Meijering, Bernadet D. M.
    Fonville, Judith M.
    de Theije, Femke K.
    [J]. JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (04) : 971 - 988